Pentazocine And Naloxone 63304-0506-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- July 31, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA075523
Active Ingredients
| Ingredient | Strength |
|---|---|
| Naloxone Hydrochloride | .5 mg/1 |
| Pentazocine | 50 mg/1 |
Drug Class
Partial Opioid Agonist/Antagonist [EPC]Competitive Opioid Antagonists [MoA]Opioid Antagonist [EPC]
Selected Package
63304-0506-01Selected100 TABLET in 1 BOTTLE (63304-506-01)